Amanote Research
Register
Sign In
Cd19
doi 10.1007/978-3-662-49054-9_688-1
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2017
Authors
H. Renz
B. Gierten
Publisher
Springer Berlin Heidelberg
Related search
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
CD19 Affinity — Is Lower Also Better?
Nature Reviews Clinical Oncology
Oncology
Axicabtagene Ciloleucel for CD19+ Plasmablastic Lymphoma
American Journal of Hematology
Hematology
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology
CD19+CD5+ Cells as Indicators of Preeclampsia
Hypertension
Internal Medicine
CD19-Targeted T Cells for Hematologic Malignancies
Cancer Journal
Cancer Research
Oncology
169. Clinically Adaptable CD19-Specific Chimeric Antigen Receptor
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
CAR-T Cells Beyond CD19, UnCAR-Ted Territory
American Journal of Hematology
Hematology
Synergistic Antitumor Effect of Bispecific CD19 X CD3 and CD19 X CD16 Diabodies in a Preclinical Model of Non-Hodgkin's Lymphoma
Journal of Immunology
Allergy
Immunology